COMMUNIQUÉS West-GlobeNewswire

Galapagos and MorphoSys present results from a Phase 1 study with MOR106 in atopic dermatitis as late-breaking abstract at the American Academy of Dermatology (AAD) meeting in San Diego
17/02/2018
MOR106 was generally well tolerated in atopic dermatitis (AD) patients 83% of patients (5 out of 6) at the highest dose reached at least 50% improvement per the atopic dermatitis area and severity index (EASI-50) at [...]
ChromaDex Chairman Stephen Allen Will Retire from Board of Directors
16/02/2018
IRVINE, Calif., Feb. 16, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corporation (NASDAQ: CDXC ), a science-based, integrated nutraceutical company devoted to pioneering technologies that improve the way people age is announcing [...]
OncBioMune Provides Update on Market Activity
16/02/2018
BATON ROUGE, La., Feb. 16, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]
Novartis new data show Cosentyx® improved quality of life over 5 years in two thirds of patients with moderate to severe plaque psoriasis
16/02/2018
Two thirds of patients on Cosentyx ® (secukinumab) reported no impact of skin disease on their quality of life over 5 years, SCULPTURE study shows[1] Findings show absolute PASI <=1/<=2/<=3 responses were [...]
Pernix Therapeutics Announces Launch of Authorized Generic Version of Treximet® by Company’s Subsidiary, Macoven Pharmaceuticals
16/02/2018
MORRISTOWN, N.J., Feb. 16, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX ), a specialty pharmaceutical company, today announced the launch of an authorized generic version of Treximet® ( [...]
HydRx Farms Ltd. (d/b/a Scientus Pharma Inc.) Announces Completion of its $15.8 Million Private Placement Offering of Common Shares
16/02/2018
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, Feb. 16, 2018 (GLOBE NEWSWIRE) -- [...]
Avinger Announces Closing of $18 Million Underwritten Public Offering
16/02/2018
REDWOOD CITY, Calif., Feb. 16, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced the closing of an underwritten [...]
Medifirst Solutions Announces a Business Update
16/02/2018
FREEHOLD, NJ, Feb. 16, 2018 (GLOBE NEWSWIRE) -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML- [...]
The Delta Companies Recognized with Best of Staffing® Awards 2018
16/02/2018
DALLAS, Feb. 16, 2018 (GLOBE NEWSWIRE) -- The Delta Companies (TDC) , a leading staffing firm for healthcare professionals nationwide, has announced it has been recognized with several Inavero Best of Staffing® Awards [...]
Inovalon to Participate at The Morgan Stanley Technology, Media & Telecom Conference
16/02/2018
BOWIE, Md., Feb. 16, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV ), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based [...]
LifeLabs, a proud member of the Digital Technology Supercluster, winner of federal funding and poised to supercharge Canada’s economy and technology sector
16/02/2018
Vancouver, BC, Feb. 16, 2018 (GLOBE NEWSWIRE) -- LifeLabs, Canada’s leading medical laboratory, celebrates Thursday’s announcement that the British Columbia-led Digital Technology Supercluster was one of the five [...]
NEOVACS :2018 Financial Calendar
16/02/2018
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE 2018 Financial Calendar Paris, February 16, 2018, 6pm CET - NEOVACS (Euronext Growth Paris : ALNEV), a leader in active immunotherapies for the treatment of autoimmune [...]
NEOVACS : Agenda financier 2018
16/02/2018
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE Agenda financier 2018 Paris et Boston, le 16 février 2018, 18h00 CET - NÉOVACS (Euronext Growth Paris : ALNEV), leader de l'immunothérapie active pour [...]
AIT Therapeutics Announces $9.82 Million Private Placement
16/02/2018
NEW YORK, Feb. 16, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with serious lung [...]
Medtronic Chairman and CEO Omar Ishrak to Speak at CEO Investor Forum 3.0
16/02/2018
DUBLIN - February 16, 2018 - Medtronic plc (NYSE: MDT ), the global leader in medical technology, today announced it will participate in the CECP CEO Investor Forum 3.0 in New York on Monday, February 26, 2018, at 4:00 [...]
Expert Dermatologists Present Latest Information at 2018 AAD Annual Meeting
16/02/2018
SAN DIEGO, Feb. 16, 2018 (GLOBE NEWSWIRE) -- The 2018 American Academy of Dermatology Annual Meeting will take place from Feb. 16 to 20 at the San Diego Convention Center. The meeting will feature the latest information [...]
BioStem Technologies Inc. Applies for Uplisting to the OTCQX Market
16/02/2018
Pompano Beach, FL, Feb. 16, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with a concentration [...]
Travelan® Revenue Grows Significantly in US and Australia
16/02/2018
Key Highlights: Immuron’s flagship product Travelan® reports revenue in excess of AUS$914K for first 6mths of FY2018 Travelan® US experienced a 250% increase in sales year over year reaching AU$335,000 Travelan® [...]
Arch Biopartners Closes Convertible Note Financing
16/02/2018
TORONTO, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX-V: ARCH ) (OTCBB: ACHFF ) announced it has closed the non-brokered, unsecured convertible note (“Note”) financing it [...]

Pages